Product image of Meropenem Kalceks (Meropenem) supplied by GNH India

Meropenem Kalceks

Active Ingredient:
Meropenem
Origin:
EU

Meropenem Kalceks (Meropenem)

Meropenem, the active ingredient in Meropenem Kalceks, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections in hospitalized patients, including intra‑abdominal, urinary, and respiratory infections, as well as meningitis and sepsis.

GNH India supplies Meropenem Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections that require intravenous therapy.

  • Complicated intra‑abdominal infections: provides bactericidal activity to achieve clinical cure.
  • Complicated urinary tract infections: eradicates resistant uropathogens for infection resolution.
  • Bacterial meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections.
  • Severe sepsis and septic shock: offers rapid bacterial clearance to support hemodynamic recovery.
  • Hospital‑acquired pneumonia: targets multidrug‑resistant organisms to improve respiratory outcomes.
  • Ventilator‑associated pneumonia: eliminates causative pathogens to reduce ventilator‑related complications.

How It Works

  • Meropenem binds to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic lysis and bactericidal activity against a wide range of Gram‑positive, Gram‑negative, and anaerobic organisms.

Side Effects

Adverse reactions may occur with meropenem therapy and are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: may be watery and self‑limiting.
  • Headache: transient and usually resolves without intervention.
  • Rash: erythematous skin eruption.
  • Infusion site reactions: pain, erythema, or phlebitis at the injection site.
  • Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects

  • Seizures: especially in patients with renal impairment or CNS disorders.
  • Anaphylaxis: severe hypersensitivity requiring immediate medical attention.
  • Clostridioides difficile colitis: antibiotic‑associated diarrhea.
  • Neutropenia: marked reduction in neutrophil count.
  • Thrombocytopenia: low platelet levels increasing bleeding risk.
  • Stevens‑Johnson syndrome: rare severe skin reaction.

Precautions & Warnings

Before initiating meropenem, clinicians should consider several safety factors.

  • Renal function: adjust dose in patients with impaired clearance.
  • Allergy history: avoid in individuals with known carbapenem hypersensitivity.
  • Seizure risk: monitor closely in patients with CNS disorders or high drug concentrations.
  • Pregnancy: use only when benefits outweigh potential risks.
  • Concomitant medications: review for possible interactions that may affect renal function or drug levels.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Meropenem may interact with other medicines, requiring attention to the interaction strength.

Major Interactions (Avoid)

  • Valproic acid: meropenem reduces serum valproate levels, increasing seizure risk.
  • Renally cleared drugs: co‑administration may require dose adjustments to prevent accumulation.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: may enhance nephrotoxic potential.
  • Aminoglycosides: additive risk of renal toxicity.
  • Probenecid: can increase meropenem plasma concentrations.
  • Anticoagulants: monitor INR as infection control may alter coagulation parameters.

Frequently Asked Questions

Meropenem Kalceks is indicated for serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, bacterial meningitis, severe sepsis and septic shock, hospital‑acquired pneumonia, and ventilator‑associated pneumonia. It is administered intravenously in hospital settings to target multidrug‑resistant organisms.

Meropenem inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins, which blocks the cross‑linking of peptidoglycan strands. This disruption weakens the cell wall, causing osmotic lysis and resulting in rapid bactericidal activity against a broad spectrum of Gram‑positive, Gram‑negative, and anaerobic bacteria.

The dosage of Meropenem Kalceks is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and other clinical factors. Healthcare professionals calculate the appropriate infusion rate and duration according to established guidelines.

Safety data for meropenem in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should discuss individual risk factors with the patient and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Meropenem shares the broad‑spectrum activity of the carbapenem class but offers a slightly higher stability against certain beta‑lactamases compared with imipenem. It is often preferred for infections where a lower risk of nephrotoxicity is desired, as it does not require co‑administration with cilastatin.

Meropenem Kalceks should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze the product. Once reconstituted, the solution should be used within the time frame specified in the product label, typically within 24 hours if refrigerated.

Meropenem Kalceks is administered intravenously, usually as a short infusion over 15‑30 minutes. The exact infusion rate and dosing schedule are determined by the treating physician based on infection severity, patient renal function, and institutional protocols.

Serious risks include the potential for seizures, especially in patients with renal impairment or pre‑existing CNS disorders, and severe allergic reactions such as anaphylaxis. Clinicians should also monitor for Clostridioides difficile‑associated colitis, neutropenia, and thrombocytopenia during treatment.

Patients with a known hypersensitivity to meropenem, other carbapenems, or any component of the formulation should not receive the drug. Caution is also advised for individuals with a history of seizures, severe renal impairment, or those receiving concomitant medications that lower the seizure threshold.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT